SARS-CoV-2 and pathological matrix remodeling mediators.
- Published in:
- Inflammation Research, 2021, v. 70, n. 8, p. 847, doi. 10.1007/s00011-021-01487-6
- By:
- Publication type:
- Article
Works matching IS 10233830 AND DT 2021 AND VI 70 AND IP 8
Results: 6
1
2
MicroRNA 452 regulates IL20RA-mediated JAK1/STAT3 pathway in inflammatory colitis and colorectal cancer.
- Published in:
- Inflammation Research, 2021, v. 70, n. 8, p. 903, doi. 10.1007/s00011-021-01486-7
- By:
- Publication type:
- Article
3
The pathophysiology of immunoporosis: innovative therapeutic targets.
- Published in:
- Inflammation Research, 2021, v. 70, n. 8, p. 859, doi. 10.1007/s00011-021-01484-9
- By:
- Publication type:
- Article
4
Pseudomonas aeruginosa outer membrane vesicles ameliorates lung ischemia–reperfusion injury by regulating the balance of regulatory T cells and Th17 cells through Tim-3 and TLR4/NF-κB pathway.
- Published in:
- Inflammation Research, 2021, v. 70, n. 8, p. 891, doi. 10.1007/s00011-021-01483-w
- By:
- Publication type:
- Article
5
Hydrogen alleviates cell damage and acute lung injury in sepsis via PINK1/Parkin-mediated mitophagy.
- Published in:
- Inflammation Research, 2021, v. 70, n. 8, p. 915, doi. 10.1007/s00011-021-01481-y
- By:
- Publication type:
- Article
6
The role of 5-lipoxygenase in the pathophysiology of COVID-19 and its therapeutic implications.
- Published in:
- Inflammation Research, 2021, v. 70, n. 8, p. 877, doi. 10.1007/s00011-021-01473-y
- By:
- Publication type:
- Article